4//SEC Filing
Reinhart Harald 4
Accession 0000905148-24-000061
CIK 0001704292other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:25 PM ET
Size
11.1 KB
Accession
0000905148-24-000061
Insider Transaction Report
Form 4
Zai Lab LtdZLAB
Reinhart Harald
Chief Medical Officer
Transactions
- Exercise/Conversion
American Depositary Shares
2024-01-01+17,548→ 50,863 total - Award
Performance-Based Share Units
2024-01-01+17,548→ 17,548 total→ American Depositary Shares (17,548 underlying) - Sale
American Depositary Shares
2024-01-03$26.12/sh−4,803$125,464→ 46,060 total - Exercise/Conversion
Performance-Based Share Units
2024-01-01−17,548→ 0 total→ American Depositary Shares (17,548 underlying)
Footnotes (5)
- [F1]Each American Depositary Share (ADS) represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
- [F2]ADSs acquired on vesting of performance-based share units (PSUs). Each ADS represents ten Ordinary Shares of the issuer.
- [F3]Each PSU represents a contingent right to receive one ADS, which represents ten Ordinary Shares of the issuer.
- [F4]These ADSs were sold automatically to cover taxes upon vesting of PSUs.
- [F5]The reporting person was granted PSUs on December 1, 2021 that vest based on the satisfaction of specified performance criteria between December 1, 2021 and December 31, 2025. On January 1, 2024, the performance-based vesting conditions were confirmed for PSUs representing 17,548 ADSs.
Documents
Issuer
Zai Lab Ltd
CIK 0001704292
Entity typeother
Related Parties
1- filerCIK 0001835824
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:25 PM ET
- Size
- 11.1 KB